We are live on ! Find out more
FL

Fort LP Portfolio holdings

AUM $39.6M
1-Year Est. Return 37.11%
This Fund
S&P 500
This Quarter Est. Return
+0.71%
1 Year Est. Return
+37.11%
3 Year Est. Return
+56.81%
5 Year Est. Return
+128.28%
10 Year Est. Return
+343.79%
AUM
$407M
AUM Growth
+$5.75M
Cap. Flow
+$6.49M
Cap. Flow %
1.6%
Top 10 Hldgs %
52.6%
Holding
53
New
5
Increased
20
Reduced
17
Closed
11

Top Buys

Rank Stock Value
1
OMC icon
Omnicom Group
OMC
+$10.7M
2
CVS icon
CVS Health
CVS
+$10.4M
3
MD icon
Pediatrix Medical
MD
+$9.28M
4
GILD icon
Gilead Sciences
GILD
+$8.98M
5
WU icon
Western Union
WU
+$8.45M

Top Sells

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$13.2M
2
HRB icon
H&R Block
HRB
+$10.1M
3
IDCC icon
InterDigital
IDCC
+$9.43M
4
CA
CA, Inc.
CA
+$8.88M
5
CSGS
CSG Systems International
CSGS
+$5.39M

Sector Composition

Rank Sector Weight
1 Healthcare 37.4%
2 Technology 26.77%
3 Communication Services 13.71%
4 Consumer Discretionary 5.49%
5 Financials 4.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HUM icon
1
Humana
HUM
$48B
$31.2M 7.66%
127,905
-8,294
-6% -$2.03M
WCG
2
DELISTED
Wellcare Health Plans, Inc.
WCG
$30.1M 7.42%
175,558
+25,117
+17% +$4.4M
CSCO icon
3
Cisco
CSCO
$441B
$25.2M 6.19%
748,150
+233,531
+45% +$7.43M
AMCX icon
4
AMC Global Media
AMCX
$461M
$20.8M 5.12%
355,785
-35,009
-9% -$2.08M
GIB icon
5
CGI
GIB
$14.3B
$20.6M 5.08%
398,064
+24,222
+6% +$1.24M
GILD icon
6
Gilead Sciences
GILD
$167B
$19.8M 4.88%
244,713
+117,422
+92% +$8.98M
TARO
7
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$18.4M 4.53%
163,526
-15,479
-9% -$1.68M
ELV icon
8
Elevance Health
ELV
$80.9B
$17.2M 4.24%
90,780
-69,586
-43% -$13.2M
OMC icon
9
Omnicom Group
OMC
$23.3B
$16.4M 4.04%
221,549
+139,311
+169% +$10.7M
AAPL icon
10
Apple
AAPL
$4.9T
$14M 3.45%
364,500
-10,336
-3% -$401K
HRB icon
11
H&R Block
HRB
$5.33B
$13.9M 3.42%
524,855
-346,908
-40% -$10.1M
WU icon
12
Western Union
WU
$2.77B
$13.8M 3.4%
719,860
+443,239
+160% +$8.45M
CVS icon
13
CVS Health
CVS
$137B
$13.8M 3.39%
169,356
+130,905
+340% +$10.4M
ESRX
14
DELISTED
Express Scripts Holding Company
ESRX
$13.3M 3.27%
210,090
-85,010
-29% -$5.28M
ABBV icon
15
AbbVie
ABBV
$450B
$11.6M 2.86%
130,697
+7,336
+6% +$558K
FFIV icon
16
F5
FFIV
$23.1B
$10.1M 2.48%
83,567
+62,551
+298% +$7.55M
CA
17
DELISTED
CA, Inc.
CA
$9.29M 2.29%
278,319
-268,645
-49% -$8.88M
IPG
18
DELISTED
Interpublic Group of Companies
IPG
$9.11M 2.24%
438,312
-205,220
-32% -$4.46M
MD icon
19
Pediatrix Medical
MD
$2.15B
$8.93M 2.2%
207,128
+195,295
+1,650% +$9.28M
DLX icon
20
Deluxe
DLX
$1.19B
$8.82M 2.17%
+120,888
New +$8.43M
ORCL icon
21
Oracle
ORCL
$364B
$8.12M 2%
167,927
-75,850
-31% -$3.77M
AMN icon
22
AMN Healthcare
AMN
$1.36B
$7.41M 1.82%
+162,214
New +$6.2M
TFCFA
23
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$7.23M 1.78%
274,233
+244,781
+831% +$6.74M
AMGN icon
24
Amgen
AMGN
$198B
$7.08M 1.74%
37,966
+13,036
+52% +$2.31M
KLAC icon
25
KLA
KLAC
$278B
$6.67M 1.64%
629,180
+473,120
+303% +$4.52M

Similar funds

Fort LP's Q3 2017 Portfolio in Review

As of Q3 2017, Fort LP held 53 positions worth $407M, up 1.4% from $401M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Fort LP's Q3 2017 filing shows 5 new, 20 increased, 17 reduced and 11 closed positions. Its largest new stake was Deluxe: 120,888 shares worth $8.82M. The largest sale was Elevance Health, an estimated $13.2M.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 34% a quarter earlier, followed by Technology and Communication Services.

  • Fort LP's largest Q3 2017 buy was Deluxe: 120,888 shares worth $8.82M.
  • Fort LP added most to Omnicom Group in Q3 2017, an estimated $10.7M increase.
  • Fort LP's biggest Q3 2017 reduction was Elevance Health, cutting an estimated $13.2M.
  • Fort LP fully exited Cal-Maine in Q3 2017, selling an estimated $5.22M.
  • Fort LP's ten largest holdings make up 53% of its $407M portfolio in Q3 2017.
  • Fort LP opened 5 new positions and closed 11 in Q3 2017.
  • Fort LP's portfolio value rose 1.4% quarter-over-quarter to $407M.

Based on Fort LP's 13F filing for Q3 2017, filed 13 Nov 2017.